SALE ON NOW! PROMOTIONS
Dr. Sánchez Ferro specialized in neurology at the Hospital 12 de Octubre in Madrid (Spain). In the same center, he was trained specifically for the management of Parkinson's disease thanks to a program of the Carlos III Research Institute (Río Hortega Program). During this period, he visited prestigious centers such as the ""Hertie Institut"" in Tübingen (Germany) and the ""MINDS laboratory"" from Harvard University where he also received training in neurodegenerative diseases. In 2013, Dr. Sánchez Ferro received a scholarship from a program of the Community of Madrid and the Massachusetts Institute of Technology (Cambridge, USA) to be part of a biomedical innovation program. As part of it, he developed new methods for the objective quantification of Parkinson's disease signs. Currently, Dr. Sánchez-Ferro continues applying these skills in his position as neurologist and researcher at 12 de Octubre Hospital and Chief Medical Officer of Leuko Labs. He is also Director of the Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS) and is an active member of the Technology Study Group of the MDS Society. Dr Monje specialized in neurology at the Hospital Clínico San Carlos in Madrid (Spain). She received her PhD in Neuroscience from Universidad Autónoma de Madrid working in a progressive model of Parkinson’s disease in non-human primate. She posteriorly pursued a clinical and research fellowship in Movement in HM-CINAC, where she got experience in new technologies for the objective quantification of movement disorders. Currently, Dr. Monje works as postdoctoral scholar in Northwestern University, Chicago (USA). She is the co-Chair of the Electronic Clinical Outcomes Assessment Program at the International Parkinson and Movement Disorders Society (MDS).
*4 stars* ""…a short but dense text focused entirely on the use of digital technologies and artificial intelligence techniques to measure and to understand movement disorders....[explaining] clinical findings [on] the use of wearable sensors to measure and record movement and clinical instruments, including patient-reported outcome measures, to assess movement in patients with these disorders. ....[Helps] readers understand the technological breakthroughs in assessment.... [and] addresses innovative topics such as functional neurosurgical techniques and ultrasound treatment…. The figures and diagrams ae well-done and very important....very well-referenced."" — ©Doody’s Review Service, 2024, Elliot J Roth, MD (Shirley Ryan AbilityLab)
Ending Parkinson's Disease
A Prescription for Action
Paperback
$29.99
Not in-store but you can order this
Overcoming Multiple Sclerosis Handbook...
Roadmap to good health
Paperback
$36.99
Not in-store but you can order this
My Life with MS, Bipolar and Brain...
Living in the Moment
Hardback
$273
Not in-store but you can order this
